Canada’s drug price controls undercut American innovation, critics say - The Center Square
  Medicare's New Drug Price Mandate: Healthcare ' Innovation Implications - The Federalist Society
  Extensive patent strategies drive U.S. drug price disparities - TechTarget
  Oz hints at impending CMS rule to force drug price transparency - Healthcare Dive
  The Trump Administration’s Drug Price Actions and Why US Prices Are Already Sky-High - Center for Biosimilars
  Parliamentarian reverses course on rare disease drug price provision in tax bill - Washington Examiner
  Opinion
  Trump to pitch sweeping Medicare drug price plan - Politico